Clorox (NYSE:CLX) Given New $142.00 Price Target at Evercore ISI

Clorox (NYSE:CLXFree Report) had its target price trimmed by Evercore ISI from $145.00 to $142.00 in a research report sent to investors on Wednesday morning, Benzinga reports. The brokerage currently has an underperform rating on the stock.

CLX has been the subject of a number of other research reports. DA Davidson reissued a neutral rating and issued a $162.00 target price on shares of Clorox in a research report on Wednesday, April 17th. Deutsche Bank Aktiengesellschaft reduced their price objective on Clorox from $155.00 to $151.00 and set a hold rating for the company in a research report on Wednesday, April 17th. The Goldman Sachs Group started coverage on shares of Clorox in a report on Friday, March 1st. They issued a sell rating and a $140.00 target price for the company. Jefferies Financial Group raised shares of Clorox from an underperform rating to a hold rating and set a $145.00 target price for the company in a report on Tuesday, March 26th. Finally, Barclays reduced their target price on shares of Clorox from $148.00 to $136.00 and set an underweight rating for the company in a report on Wednesday, April 10th. Four research analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of Hold and an average price target of $146.43.

Get Our Latest Report on Clorox

Clorox Stock Down 1.0 %

NYSE:CLX opened at $138.23 on Wednesday. The firm’s 50-day moving average price is $148.74 and its 200-day moving average price is $143.08. The company has a market capitalization of $17.17 billion, a PE ratio of 71.62, a P/E/G ratio of 2.08 and a beta of 0.44. The company has a debt-to-equity ratio of 9.73, a current ratio of 0.90 and a quick ratio of 0.57. Clorox has a 1-year low of $114.68 and a 1-year high of $176.24.

Clorox (NYSE:CLXGet Free Report) last released its earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, topping analysts’ consensus estimates of $1.33 by $0.38. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The firm had revenue of $1.81 billion for the quarter, compared to the consensus estimate of $1.87 billion. During the same period in the prior year, the firm earned $1.51 EPS. The company’s revenue was down 5.3% compared to the same quarter last year. On average, equities analysts predict that Clorox will post 5.85 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 10th. Shareholders of record on Wednesday, April 24th will be paid a dividend of $1.20 per share. This represents a $4.80 annualized dividend and a yield of 3.47%. The ex-dividend date is Tuesday, April 23rd. Clorox’s payout ratio is 248.70%.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently bought and sold shares of the company. Venturi Wealth Management LLC boosted its stake in Clorox by 308.5% during the first quarter. Venturi Wealth Management LLC now owns 192 shares of the company’s stock worth $29,000 after buying an additional 145 shares during the period. Northwest Financial Advisors purchased a new position in Clorox during the fourth quarter worth $29,000. GoalVest Advisory LLC purchased a new position in Clorox during the first quarter worth $31,000. Core Wealth Advisors Inc. purchased a new stake in shares of Clorox during the fourth quarter valued at $29,000. Finally, Fortitude Family Office LLC purchased a new stake in shares of Clorox during the fourth quarter valued at $29,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Company Profile

(Get Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Read More

Analyst Recommendations for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.